ClinicalTrials.Veeva

Menu

Non-invasive Brain Stimulation for Gait Improvement in Patients With Spinal Cord Injury (SCI)

G

Guttmann Institute

Status and phase

Completed
Phase 3

Conditions

Functional Improvement

Treatments

Device: rTMS
Device: sham rTMS

Study type

Interventional

Funder types

Other

Identifiers

NCT02711319
PI10/00442

Details and patient eligibility

About

to optimize the functional outcome in early phase of gait rehabilitation in subacute incomplete SCI patients using rTMS as an additional treatment to physical therapy (e.g. to gait training in Lokomat®). Using this add-on therapeutic strategy, we expected larger improvement of gait function than with physical therapy alone.

Full description

Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive and painless procedure to modulate cortical excitability of motor areas and induce changes over the descending corticospinal output. This modulation may be useful to promote active recovery of motor function and to obtain functional benefit from gait rehabilitation. Through the use of repetitive high-frequency rTMS, improvement has been reported in motor and sensory functions measured by American Spinal Cord Injury Association (ASIA) Impairment Scale (AIS), and time to complete a peg-board task in four chronic incomplete cervical SCI patients.

Physical therapy aims to improve function of both undamaged and also, as far as possible, damaged neuronal structures. However, 'reorganization' of neuronal circuits is the target of specific training approaches. Therefore, the challenge is to guide CNS plasticity in order to optimize the functional outcome for a given individual. Hypothesized was that high-frequency rTMS coupled with gait training can improve motor recovery in the lower extremities and locomotion in incomplete SCI patients to a greater degree than sham stimulation.

Enrollment

31 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. had subacute motor incomplete SCI (AIS-C or D),
  2. candidate for gait rehabilitation with Lokomat® after cervical or thoracic SCI;
  3. stable medical treatment at least one week before and during the study;
  4. without limitation of passive range of movement in joints
  5. agreed to participate after signing a written informed consent form.

Exclusion criteria

  1. unstable clinical state
  2. severe spasticity (MAS>=3)
  3. disagreed to sign consent form

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

31 participants in 2 patient groups

active (real) rTMS (ACTIVE GROUP)
Active Comparator group
Description:
The patients were randomly distributed in two study groups: real or sham rTMS group. For real rTMS, we applied 2 seconds duration bursts of 20 Hz (40 pulses/burst) with intertrain intervals of 28 seconds, for a total of 1800 pulses over 20 minutes.
Treatment:
Device: rTMS
sham rTMS (SHAM GROUP)
Sham Comparator group
Description:
For sham rTMS, the double cone coil was again held over the vertex, but it was disconnected from the main stimulator unit. Instead, a second coil (8-shaped) was connected to the MagStim stimulator, and discharged under the patient's pillow (2).
Treatment:
Device: sham rTMS

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems